TIEG1/KLF10 modulates runx2 expression and activity in osteoblasts

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Hawse, John R ^a   Cicek, Muzaffer ^a   Grygo, Sarah B ^a   Bruinsma, Elizabeth S ^a   Rajamannan, Nalini M ^b   van Wijnen, Andre J ^c   Lian, Jane B ^c   Stein, Gary S ^c   Oursler, Merry Jo ^d   Subramaniam, Malayannan ^a   Spelsberg, Thomas C ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR; PROTEASOME; TGF BETA INDUCIBLE EARLY GENE 1 PROTEIN; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA1; UBIQUITIN; UNCLASSIFIED DRUG; DNA; DNA BINDING PROTEIN; EARLY GROWTH RESPONSE FACTOR; KLF10 PROTEIN, HUMAN; RUNX2 PROTEIN, HUMAN; RUNX2 PROTEIN, MOUSE; TIEG1 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ADENOVIRUS INFECTION; ARTICLE; BONE MINERALIZATION; CALVARIA; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA BINDING; HUMAN; HUMAN CELL; OSTEOBLAST; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; TRANSCRIPTION INITIATION; ZINC FINGER MOTIF; ANIMAL; CHEMISTRY; CYTOLOGY; FEMALE; GENE EXPRESSION REGULATION; METABOLISM; MOLECULAR GENETICS; MOUSE; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALIA; MUS;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DNA; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE TRANSCRIPTION FACTORS; FEMALE; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; OSTEOBLASTS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79955759697     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019429     Document Type: Article

References (74)

1. Subramaniam M, Harris SA, Oursler MJ, Rasmussen K, Riggs BL, et al. (1995) Identification of a novel TGF-beta-regulated gene encoding a putative zinc finger protein in human osteoblasts. Nucleic Acids Res 23: 4907-4912.
2. Hawse JR, Subramaniam M, Monroe DG, Hemmingsen AH, Ingle JN, et al. (2008) Estrogen receptor beta isoform-specific induction of transforming growth factor beta-inducible early gene-1 in human osteoblast cells: an essential role for the activation function 1 domain. Mol Endocrinol 22: 1579-1595.
3. Hefferan TE, Subramaniam M, Khosla S, Riggs BL, Spelsberg TC, (2000) Cytokine-specific induction of the TGF-beta inducible early gene (TIEG): regulation by specific members of the TGF-beta family. J Cell Biochem 78: 380-390.
4. Subramaniam M, Hawse JR, Rajamannan NM, Ingle JN, Spelsberg TC, (2010) Functional role of KLF10 in multiple disease processes. Biofactors.
5. Johnsen SA, Subramaniam M, Janknecht R, Spelsberg TC, (2002) TGFbeta inducible early gene enhances TGFbeta/Smad-dependent transcriptional responses. Oncogene 21: 5783-5790.
6. Johnsen SA, Subramaniam M, Effenberger KE, Spelsberg CT, (2004) The TGF-beta inducible early gene plays a central role in the anti-proliferative response to TGF-beta. Signal Transduction 4: 29-35.
7. Hefferan TE, Reinholz GG, Rickard DJ, Johnsen SA, Waters KM, et al. (2000) Overexpression of a nuclear protein, TIEG, mimics transforming growth factor-beta action in human osteoblast cells. J Biol Chem 275: 20255-20259.
8. Tachibana I, Imoto M, Adjei PN, Gores GJ, Subramaniam M, et al. (1997) Overexpression of the TGFbeta-regulated zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells. J Clin Invest 99: 2365-2374.
9. Chalaux E, Lopez-Rovira T, Rosa JL, Pons G, Boxer LM, et al. (1999) A zinc-finger transcription factor induced by TGF-beta promotes apoptotic cell death in epithelial Mv1Lu cells. FEBS Lett 457: 478-482.
10. Reinholz MM, An MW, Johnsen SA, Subramaniam M, Suman VJ, et al. (2004) Differential gene expression of TGF beta inducible early gene (TIEG), Smad7, Smad2 and Bard1 in normal and malignant breast tissue. Breast Cancer Res Treat 86: 75-88.
11. Subramaniam M, Gorny G, Johnsen SA, Monroe DG, Evans GL, et al. (2005) TIEG1 null mouse-derived osteoblasts are defective in mineralization and in support of osteoclast differentiation in vitro. Mol Cell Biol 25: 1191-1199.
12. Rajamannan NM, Subramaniam M, Abraham TP, Vasile VC, Ackerman MJ, et al. (2007) TGFbeta inducible early gene-1 (TIEG1) and cardiac hypertrophy: Discovery and characterization of a novel signaling pathway. J Cell Biochem 100: 315-325.
13. Tsubone T, Moran SL, Subramaniam M, Amadio PC, Spelsberg TC, et al. (2006) Effect of TGF-beta inducible early gene deficiency on flexor tendon healing. J Orthop Res 24: 569-575.
14. Bensamoun SF, Tsubone T, Subramaniam M, Hawse JR, Boumediene E, et al. (2006b) Age-dependent changes in the mechanical properties of tail tendons in TGF-beta inducible early gene-1 knockout mice. J Appl Physiol 101: 1419-1424.
15. Venuprasad K, Huang H, Harada Y, Elly C, Subramaniam M, et al. (2008) The E3 ubiquitin ligase Itch regulates expression of transcription factor Foxp3 and airway inflammation by enhancing the function of transcription factor TIEG1. Nat Immunol 9: 245-253.
16. Cao Z, Wara AK, Icli B, Sun X, Packard RR, et al. (2009) Kruppel-like factor KLF10 targets transforming growth factor-beta1 to regulate CD4(+)CD25(-) T cells and T regulatory cells. J Biol Chem 284: 24914-24924.
17. Bensamoun SF, Hawse JR, Subramaniam M, Ilharreborde B, Bassillais A, et al. (2006a) TGFbeta inducible early gene-1 knockout mice display defects in bone strength and microarchitecture. Bone 39: 1244-1251.
18. Hawse JR, Iwaniec UT, Bensamoun SF, Monroe DG, Peters KD, et al. (2008) TIEG-null mice display an osteopenic gender-specific phenotype. Bone 42: 1025-1031.
19. Haddad O, Hawse JR, Subramaniam M, Spelsberg TC, Bensamoun FS, (2009) TIEG1-null osteocytes display defects in their morphology, density and surrounding bone matrix. J Musculoskeletal Research 12: 127-136.
20. Subramaniam M, Hawse JR, Johnsen SA, Spelsberg TC, (2007) Role of TIEG1 in biological processes and disease states. J Cell Biochem 102: 539-548.
21. Subramaniam M, Hawse JR, Bruinsma ES, Grygo SB, Cicek M, et al. (2010) TGFbeta inducible early gene-1 directly binds to, and represses, the OPG promoter in osteoblasts. Biochem Biophys Res Commun 392: 72-76.
22. Pratap J, Galindo M, Zaidi SK, Vradii D, Bhat BM, et al. (2003) Cell growth regulatory role of Runx2 during proliferative expansion of preosteoblasts. Cancer Res 63: 5357-5362.
23. Galindo M, Pratap J, Young DW, Hovhannisyan H, Im HJ, et al. (2005) The bone-specific expression of Runx2 oscillates during the cell cycle to support a G1-related antiproliferative function in osteoblasts. J Biol Chem 280: 20274-20285.
24. Young DW, Hassan MQ, Pratap J, Galindo M, Zaidi SK, et al. (2007) Mitotic occupancy and lineage-specific transcriptional control of rRNA genes by Runx2. Nature 445: 442-446.
25. Young DW, Hassan MQ, Yang XQ, Galindo M, Javed A, et al. (2007) Mitotic retention of gene expression patterns by the cell fate-determining transcription factor Runx2. Proc Natl Acad Sci U S A 104: 3189-3194.
26. Zaidi SK, Pande S, Pratap J, Gaur T, Grigoriu S, et al. (2007) Runx2 deficiency and defective subnuclear targeting bypass senescence to promote immortalization and tumorigenic potential. Proc Natl Acad Sci U S A 104: 19861-19866.
27. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, et al. (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755-764.
28. Karsenty G, (1999) The genetic transformation of bone biology. Genes Dev 13: 3037-3051.
29. Lian JB, Javed A, Zaidi SK, Lengner C, Montecino M, et al. (2004) Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors. Crit Rev Eukaryot Gene Expr 14: 1-41.
30. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, et al. (1997) Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89: 765-771.
31. Choi JY, Pratap J, Javed A, Zaidi SK, van Wijnen AJ, et al. (2000) In vivo replacement of Runx2/Cbfa1 gene with a mutant gene lacking a subnuclear targeting signal and transcriptional regulatory functions results in severe skeletal abnormalities. J Bone Miner Res 15.
32. Lee KS, Kim HJ, Li QL, Chi XZ, Ueta C, et al. (2000) Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 20: 8783-8792.
33. Ito Y, Miyazono K, (2003) RUNX transcription factors as key targets of TGF-beta superfamily signaling. Curr Opin Genet Dev 13: 43-47.
34. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G, (1997) Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89: 747-754.
35. Gao YH, Shinki T, Yuasa T, Kataoka-Enomoto H, Komori T, et al. (1998) Potential role of cbfa1, an essential transcriptional factor for osteoblast differentiation, in osteoclastogenesis: regulation of mRNA expression of osteoclast differentiation factor (ODF). Biochem Biophys Res Commun 252: 697-702.
36. Harada H, Tagashira S, Fujiwara M, Ogawa S, Katsumata T, et al. (1999) Cbfa1 isoforms exert functional differences in osteoblast differentiation. J Biol Chem 274: 6972-6978.
37. Thirunavukkarasu K, Halladay DL, Miles RR, Yang X, Galvin RJ, et al. (2000) The osteoblast-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function. J Biol Chem 275: 25163-25172.
38. Alliston T, Choy L, Ducy P, Karsenty G, Derynck R, (2001) TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J 20: 2254-2272.
39. Kern B, Shen J, Starbuck M, Karsenty G, (2001) Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes. J Biol Chem 276: 7101-7107.
40. Geoffroy V, Kneissel M, Fournier B, Boyde A, Matthias P, (2002) High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage. Mol Cell Biol 22: 6222-6233.
41. O'Brien CA, Kern B, Gubrij I, Karsenty G, Manolagas SC, (2002) Cbfa1 does not regulate RANKL gene activity in stromal/osteoblastic cells. Bone 30: 453-462.
42. Enomoto H, Shiojiri S, Hoshi K, Furuichi T, Fukuyama R, et al. (2003) Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene. J Biol Chem 278: 23971-23977.
43. Liu W, Kato M, Itoigawa M, Murakami H, Yajima M, et al. (2001) Distinct involvement of NF-kappaB and p38 mitogen-activated protein kinase pathways in serum deprivation-mediated stimulation of inducible nitric oxide synthase and its inhibition by 4-hydroxynonenal. J Cell Biochem 83: 271-280.
44. Subramaniam M, Oursler MJ, Rasmussen K, Riggs BL, Spelsberg TC, (1995) TGF-beta regulation of nuclear proto-oncogenes and TGF-beta gene expression in normal human osteoblast-like cells. J Cell Biochem 57: 52-61.
45. Drissi H, Luc Q, Shakoori R, Chuva De Sousa Lopes S, Choi JY, et al. (2000) Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene. J Cell Physiol 184: 341-350.
46. Johnsen SA, Subramaniam M, Monroe DG, Janknecht R, Spelsberg TC, (2002) Modulation of transforming growth factor beta (TGFbeta)/Smad transcriptional responses through targeted degradation of TGFbeta-inducible early gene-1 by human seven in absentia homologue. J Biol Chem 277: 30754-30759.
47. House CM, Frew IJ, Huang HL, Wiche G, Traficante N, et al. (2003) A binding motif for Siah ubiquitin ligase. Proc Natl Acad Sci U S A 100: 3101-3106.
48. Ducy P, Karsenty G, (1995) Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol 15: 1858-1869.
49. Lian JB, Stein GS, Javed A, van Wijnen AJ, Stein JL, et al. (2006) Networks and hubs for the transcriptional control of osteoblastogenesis. Reviews in endocrine & metabolic disorders 7: 1-16.
50. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, et al. (2002) The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108: 17-29.
51. Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, et al. (1997) Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89: 773-779.
52. Satokata I, Ma L, Ohshima H, Bei M, Woo I, et al. (2000) Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nat Genet 24: 391-395.
53. Tribioli C, Lufkin T, (1999) The murine Bapx1 homeobox gene plays a critical role in embryonic development of the axial skeleton and spleen. Development 126: 5699-5711.
54. Monroe DG, Hawse JR, Subramaniam M, Spelsberg TC, (2010) Retinoblastoma binding protein-1 (RBP1) is a Runx2 coactivator and promotes osteoblastic differentiation. BMC musculoskeletal disorders 11: 104.
55. Zhang Y, Hassan MQ, Xie RL, Hawse JR, Spelsberg TC, et al. (2009) Co-stimulation of the bone-related Runx2 P1 promoter in mesenchymal cells by SP1 and ETS transcription factors at polymorphic purine-rich DNA sequences (Y-repeats). J Biol Chem 284: 3125-3135.
56. Dobreva G, Chahrour M, Dautzenberg M, Chirivella L, Kanzler B, et al. (2006) SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation. Cell 125: 971-986.
57. Schmidt K, Schinke T, Haberland M, Priemel M, Schilling AF, et al. (2005) The high mobility group transcription factor Sox8 is a negative regulator of osteoblast differentiation. J Cell Biol 168: 899-910.
58. Kim S, Koga T, Isobe M, Kern BE, Yokochi T, et al. (2003) Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation. Genes Dev 17: 1979-1991.
59. Zhou G, Zheng Q, Engin F, Munivez E, Chen Y, et al. (2006) Dominance of SOX9 function over RUNX2 during skeletogenesis. Proc Natl Acad Sci U S A 103: 19004-19009.
60. Jheon AH, Ganss B, Cheifetz S, Sodek J, (2001) Characterization of a novel KRAB/C2H2 zinc finger transcription factor involved in bone development. J Biol Chem 276: 18282-18289.
61. Kim YJ, Kim BG, Lee SJ, Lee HK, Lee SH, et al. (2007) The suppressive effect of myeloid Elf-1-like factor (MEF) in osteogenic differentiation. J Cell Physiol 211: 253-260.
62. Hinoi E, Fujimori S, Wang L, Hojo H, Uno K, et al. (2006) Nrf2 negatively regulates osteoblast differentiation via interfering with Runx2-dependent transcriptional activation. J Biol Chem 281: 18015-18024.
63. Zaidi SK, Sullivan AJ, Medina R, Ito Y, van Wijnen AJ, et al. (2004) Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription. EMBO J 23: 790-799.
64. Vega RB, Matsuda K, Oh J, Barbosa AC, Yang X, et al. (2004) Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119: 555-566.
65. Lengner CJ, Steinman HA, Gagnon J, Smith TW, Henderson JE, et al. (2006) Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling. J Cell Biol 172: 909-921.
66. Miller J, Horner A, Stacy T, Lowrey C, Lian JB, et al. (2002) The core-binding factor beta subunit is required for bone formation and hematopoietic maturation. Nat Genet 32: 645-649.
67. Yoshida CA, Furuichi T, Fujita T, Fukuyama R, Kanatani N, et al. (2002) Core-binding factor beta interacts with Runx2 and is required for skeletal development. Nat Genet 32: 633-638.
68. Kanatani N, Fujita T, Fukuyama R, Liu W, Yoshida CA, et al. (2006) Cbf beta regulates Runx2 function isoform-dependently in postnatal bone development. Dev Biol 296: 48-61.
69. Zhang YW, Yasui N, Ito K, Huang G, Fujii M, et al. (2000) A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci U S A 97: 10549-10554.
70. Luan Y, Yu XP, Xu K, Ding B, Yu J, et al. (2007) The retinoblastoma protein is an essential mediator of osteogenesis that links the p204 protein to the Cbfa1 transcription factor thereby increasing its activity. J Biol Chem 282: 16860-16870.
71. Hong JH, Hwang ES, McManus MT, Amsterdam A, Tian Y, et al. (2005) TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309: 1074-1078.
72. Hassan MQ, Tare R, Lee SH, Mandeville M, Weiner B, et al. (2007) HOXA10 controls osteoblastogenesis by directly activating bone regulatory and phenotypic genes. Mol Cell Biol 27: 3337-3352.
73. Westendorf JJ, (2006) Transcriptional co-repressors of Runx2. J Cell Biochem 98: 54-64.
74. Jones DC, Wein MN, Oukka M, Hofstaetter JG, Glimcher MJ, et al. (2006) Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3. Science 312: 1223-1227.